BeOne Medicines AG ONC
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 915.57M | 655.71M | 513.02M | 286.93M | 68.55M |
| Total Depreciation and Amortization | 150.10M | 148.51M | 139.45M | 131.68M | 146.31M |
| Total Amortization of Deferred Charges | 28.48M | 6.42M | 10.57M | 10.00M | 9.64M |
| Total Other Non-Cash Items | 521.13M | 529.24M | 542.01M | 508.06M | 552.41M |
| Change in Net Operating Assets | -25.07M | 144.18M | 79.78M | 190.90M | 8.48M |
| Cash from Operations | 1.59B | 1.48B | 1.28B | 1.13B | 785.39M |
| Capital Expenditure | -140.96M | -153.87M | -170.22M | -185.84M | -240.80M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -28.00M | -28.60M | -29.50M | -90.32M | -90.63M |
| Cash from Investing | -168.96M | -182.47M | -199.72M | -276.16M | -331.43M |
| Total Debt Issued | 920.95M | 920.95M | 1.06B | 1.08B | 765.38M |
| Total Debt Repaid | -816.15M | -812.57M | -910.97M | -1.08B | -854.02M |
| Issuance of Common Stock | 164.25M | 134.70M | 156.80M | 196.28M | 185.83M |
| Repurchase of Common Stock | 0.00 | 0.00 | -24.20M | -24.20M | -24.20M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -7.34M | 877.71M | 877.76M | 883.56M | 885.00M |
| Cash from Financing | 261.70M | 1.12B | 1.16B | 1.06B | 958.00M |
| Foreign Exchange rate Adjustments | 72.82M | 72.22M | 75.86M | 60.02M | -14.85M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.76B | 2.49B | 2.32B | 1.97B | 1.40B |